Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.5T | 8.3T | 7.3T | 7.0T |
Cost of revenue | 3.8T | 5.1T | 4.5T | 4.1T |
Gross profit | 2.7T | 3.2T | 2.8T | 3.0T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 58.7B | 158.4B | 70.9B | 73.3B |
Other operating expenses | 23.3B | 205.9B | 59.3B | 19.7B |
Operating income | 2.2T | 2.3T | 2.2T | 2.5T |
Non operating interest income | ||||
Income | 69.8B | 78.4B | 70.3B | 53.8B |
Expense | 797.2B | 818.5B | 920.0B | 939.6B |
Other income expense | — | — | — | — |
Pretax income | 1.5T | 1.9T | 1.3T | 1.7T |
Tax provision | 310.9B | 227.5B | 191.8B | -618.3B |
Net income | 1.2T | 1.7T | 1.1T | 2.3T |
Basic EPS | 127.8 | — | — | — |
Diluted EPS | 127.8 | — | — | — |
Basic average shares | 7.3B | — | — | — |
Diluted average shares | 7.3B | — | — | — |
EBITDA | 2.3T | 2.4T | 2.2T | 2.6T |
Net income from continuing op. | — | — | — | — |
Minority interests | -278.9B | -416.6B | -137.1B | -510.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |